+987.9%
MRNA vs MSTZ
-63.1%
+1,051.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MSTZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -9.6% | +22.7% | +10.4% |
| 7D | +20.6% | +0.7% | +19.9% | +21.8% |
| 30D | +27.1% | +16.6% | +10.6% | +37.1% |
| 3M | +353.4% | -74.7% | +428.1% | +242.8% |
| 6M | +446.3% | -43.9% | +490.2% | +373.8% |
| YTD | +776.2% | -84.0% | +860.2% | +628.6% |
| 1Y | +987.9% | -65.1% | +1,053.0% | +903.9% |
| All | +987.9% | -63.1% | +1,051.0% | +903.9% |
Cumulative growth
Daily Returns
Daily percentage return beside MSTZ.
Daily Out/Under-Performance
Portfolio return minus MSTZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MSTZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MSTZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling